Mar 16 | Sep 15 | Mar 15 | Sep 14 | Mar 14 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | € 28.00K | € 2.00M | € 208.00K | € 3.50M | € 189.00K |
Total Assets | € 524.36M | € 510.20M | € 515.94M | € 503.10M | € 506.45M |
Total Debt | € 0.00 | € 0.00 | € 0.00 | € 0.00 | € 0.00 |
Net Debt | € -28.00K | € -2.00M | € -208.00K | € -3.50M | € -189.00K |
Total Liabilities | € 215.41M | € 198.20M | € 206.99M | € 189.10M | € 197.50M |
Stockholders Equity | € 308.95M | € 312.00M | € 308.95M | € 314.00M | € 308.95M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |